W. Eiermann
Technische Universität München
9 Papers
56 Citations
W. Eiermann is an academic researcher from Technische Universität München. The author has contributed to research in topics: Radiation therapy & Breast cancer. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
Jayant S. Vaidya,Max Bulsara,Michael Baum,Frederik Wenz,Samuele Massarut,Steffi Pigorsch,Michael Alvarado,Michael Douek,Christobel Saunders,Henrik Flyger,W. Eiermann,Chris Brew-Graves,Norman R. Williams,Ingrid Potyka,Nicholas Roberts,Marcelle Bernstein,Douglas Brown,Elena Sperk,Siobhan Laws,Marc Sütterlin,Tammy Corica,Steinar Lundgren,Dennis R. Holmes,Lorenzo Vinante,Fernando Bozza,Montserrat Pazos,Magali Le Blanc-Onfroy,Günther Gruber,Wojciech Polkowski,Konstantin J. Dedes,Marcus Niewald,Jens Uwe Blohmer,David R. McCready,Richard A. Hoefer,Pond R. Kelemen,Gloria Petralia,Mary Falzon,David Joseph,Jeffrey S Tobias +38 more
TL;DR: For patients with early breast cancer who met the trial selection criteria, risk adapted immediate single dose TARGIT-IORT during lumpectomy was an effective alternative to EBRT, with comparable long term efficacy for cancer control and lower non-breast cancer mortality.
231
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer
Jayant S. Vaidya,Max Bulsara,Max Bulsara,Christobel Saunders,Henrik Flyger,Jeffrey S Tobias,Tammy Corica,Samuele Massarut,Frederik Wenz,Steffi Pigorsch,Michael Alvarado,Michael Douek,W. Eiermann,Chris Brew-Graves,Norman R. Williams,Ingrid Potyka,Nicholas Roberts,Marcelle Bernstein,Douglas Brown,Elena Sperk,Siobhan Laws,Marc Sütterlin,Steinar Lundgren,Dennis R. Holmes,Lorenzo Vinante,Fernando Bozza,Montserrat Pazos,Magali Le Blanc-Onfroy,Günther Gruber,Wojciech Polkowski,Konstantin J. Dedes,Marcus Niewald,Jens Uwe Blohmer,David R. McCready,Richard A. Hoefer,Pond R. Kelemen,Gloria Petralia,Mary Falzon,Michael Baum,David Joseph +39 more
TL;DR: For early breast cancer, delayed second-procedure single-dose TARGIT-IORT given by reopening the lumpectomy wound had similar long-term mastectomy-free and overall survival compared with EBRT despite higher local recurrence.
94
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer
Jayant S. Vaidya,Max Bulsara,Michael Baum,Frederik Wenz,Samuele Massarut,Steffi Pigorsch,Michael Alvarado,Michael Douek,Christobel Saunders,Henrik Flyger,W. Eiermann,Chris Brew-Graves,Norman R. Williams,Ingrid Potyka,Nicholas Roberts,Marcelle Bernstein,Douglas Brown,Elena Sperk,Siobhan Laws,Marc Sütterlin,Tammy Corica,Steinar Lundgren,Dennis R. Holmes,Lorenzo Vinante,Fernando Bozza,Montserrat Pazos,Magali Le Blanc-Onfroy,Günther Gruber,Wojciech Polkowski,Konstantin J. Dedes,Marcus Niewald,Jens Uwe Blohmer,David McReady,Richard A. Hoefer,Pond R. Kelemen,Gloria Petralia,Mary Falzon,David Joseph,Jeffrey S Tobias +38 more
TL;DR: The TARGIT-A trial reported risk-adapted targeted intraoperative radiotherapy (TARMIT-IORT) during lumpectomy for breast cancer to be as effective as EBRT as mentioned in this paper.
Targeted intraoperative radiotherapy for early breast cancer: TARGIT-A trial- updated analysis of local recurrence and first analysis of survival
Jayant S. Vaidya,F. Wenz,Max Bulsara,David Joseph,JS Tobias,M.R.S. Keshtgar,Henrik Flyger,Samuele Massarut,Michael Alvarado,Christobel Saunders,W. Eiermann,M Metaxas,Elena Sperk,Marc Sütterlin,Douglas Brown,Laura J. Esserman,Mario Roncadin,Alastair M. Thompson,John Dewar,H Holtveg,Steffi Pigorsch,Mary Falzon,Eleanor E.R. Harris,A Matthews,CB Graves,Ingrid Potyka,Tammy Corica,Norman R. Williams,Michael Baum +28 more
- 15 Dec 2012
31
HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics
Beyhan Ataseven,Daniela Gologan,Angela Gunesch,Victoria Kehl,Bernhard Hoegel,Michaela Beer,W. Eiermann +6 more
TL;DR: It is essential to analyze whether biological markers of BC relate to identical expression profiles of metastatic lymph nodes (mLNs) and whether these discrepancies have an effect on patient survival.